Looking to establish a “hub” in the cell therapy ecosystem, the Novo Nordisk Foundation is pumping 950 million Danish kroner (about $136 million) into a new clinical production site at the Technical University of Denmark (DTU) in Lyngby. Construction is due to kick off next summer, and the site is expected to be operational in 2027. Source: Fierce Pharma 21/9/2023